Cargando…

Scale-Up Synthesis and Identification of GLYX-13, a NMDAR Glycine-Site Partial Agonist for the Treatment of Major Depressive Disorder

GLYX-13, a NMDAR glycine-site partial agonist, was discovered as a promising antidepressant with rapidly acting effects but no ketamine-like side effects. However, the reported synthetic process route had deficiencies of low yield and the use of unfriendly reagents. Here, we report a scaled-up synth...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Wenchao, Liu, Jingjian, Fan, Minghua, Li, Zhongtang, Chen, Yin, Zhang, Guisen, Huang, Zhuo, Zhang, Liangren
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6102568/
https://www.ncbi.nlm.nih.gov/pubmed/29695090
http://dx.doi.org/10.3390/molecules23050996
_version_ 1783349193523331072
author Li, Wenchao
Liu, Jingjian
Fan, Minghua
Li, Zhongtang
Chen, Yin
Zhang, Guisen
Huang, Zhuo
Zhang, Liangren
author_facet Li, Wenchao
Liu, Jingjian
Fan, Minghua
Li, Zhongtang
Chen, Yin
Zhang, Guisen
Huang, Zhuo
Zhang, Liangren
author_sort Li, Wenchao
collection PubMed
description GLYX-13, a NMDAR glycine-site partial agonist, was discovered as a promising antidepressant with rapidly acting effects but no ketamine-like side effects. However, the reported synthetic process route had deficiencies of low yield and the use of unfriendly reagents. Here, we report a scaled-up synthesis of GLYX-13 with an overall yield of 30% on the hectogram scale with a column chromatography-free strategy, where the coupling and deprotection reaction conditions were systematically optimized. Meanwhile, the absolute configuration of precursor compound of GLYX-13 was identified by X-ray single crystal diffraction. Finally, the activity of GLYX-13 was verified in the cortical neurons of mice through whole-cell voltage-clamp technique.
format Online
Article
Text
id pubmed-6102568
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-61025682018-11-13 Scale-Up Synthesis and Identification of GLYX-13, a NMDAR Glycine-Site Partial Agonist for the Treatment of Major Depressive Disorder Li, Wenchao Liu, Jingjian Fan, Minghua Li, Zhongtang Chen, Yin Zhang, Guisen Huang, Zhuo Zhang, Liangren Molecules Article GLYX-13, a NMDAR glycine-site partial agonist, was discovered as a promising antidepressant with rapidly acting effects but no ketamine-like side effects. However, the reported synthetic process route had deficiencies of low yield and the use of unfriendly reagents. Here, we report a scaled-up synthesis of GLYX-13 with an overall yield of 30% on the hectogram scale with a column chromatography-free strategy, where the coupling and deprotection reaction conditions were systematically optimized. Meanwhile, the absolute configuration of precursor compound of GLYX-13 was identified by X-ray single crystal diffraction. Finally, the activity of GLYX-13 was verified in the cortical neurons of mice through whole-cell voltage-clamp technique. MDPI 2018-04-24 /pmc/articles/PMC6102568/ /pubmed/29695090 http://dx.doi.org/10.3390/molecules23050996 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Li, Wenchao
Liu, Jingjian
Fan, Minghua
Li, Zhongtang
Chen, Yin
Zhang, Guisen
Huang, Zhuo
Zhang, Liangren
Scale-Up Synthesis and Identification of GLYX-13, a NMDAR Glycine-Site Partial Agonist for the Treatment of Major Depressive Disorder
title Scale-Up Synthesis and Identification of GLYX-13, a NMDAR Glycine-Site Partial Agonist for the Treatment of Major Depressive Disorder
title_full Scale-Up Synthesis and Identification of GLYX-13, a NMDAR Glycine-Site Partial Agonist for the Treatment of Major Depressive Disorder
title_fullStr Scale-Up Synthesis and Identification of GLYX-13, a NMDAR Glycine-Site Partial Agonist for the Treatment of Major Depressive Disorder
title_full_unstemmed Scale-Up Synthesis and Identification of GLYX-13, a NMDAR Glycine-Site Partial Agonist for the Treatment of Major Depressive Disorder
title_short Scale-Up Synthesis and Identification of GLYX-13, a NMDAR Glycine-Site Partial Agonist for the Treatment of Major Depressive Disorder
title_sort scale-up synthesis and identification of glyx-13, a nmdar glycine-site partial agonist for the treatment of major depressive disorder
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6102568/
https://www.ncbi.nlm.nih.gov/pubmed/29695090
http://dx.doi.org/10.3390/molecules23050996
work_keys_str_mv AT liwenchao scaleupsynthesisandidentificationofglyx13anmdarglycinesitepartialagonistforthetreatmentofmajordepressivedisorder
AT liujingjian scaleupsynthesisandidentificationofglyx13anmdarglycinesitepartialagonistforthetreatmentofmajordepressivedisorder
AT fanminghua scaleupsynthesisandidentificationofglyx13anmdarglycinesitepartialagonistforthetreatmentofmajordepressivedisorder
AT lizhongtang scaleupsynthesisandidentificationofglyx13anmdarglycinesitepartialagonistforthetreatmentofmajordepressivedisorder
AT chenyin scaleupsynthesisandidentificationofglyx13anmdarglycinesitepartialagonistforthetreatmentofmajordepressivedisorder
AT zhangguisen scaleupsynthesisandidentificationofglyx13anmdarglycinesitepartialagonistforthetreatmentofmajordepressivedisorder
AT huangzhuo scaleupsynthesisandidentificationofglyx13anmdarglycinesitepartialagonistforthetreatmentofmajordepressivedisorder
AT zhangliangren scaleupsynthesisandidentificationofglyx13anmdarglycinesitepartialagonistforthetreatmentofmajordepressivedisorder